The partners of Fund X are Jim Healy, MD, PhD, Mike Powell, PhD, Anand Mehra, MD, Sunil Agarwal, MD, Lars Ekman, MD, PhD, David Kabakoff, PhD and Dan Welch.
Founded in 1974, Sofinnova specializes in clinical and late preclinical investments in biopharmaceutical products. Our goal is to actively partner with entrepreneurs across all stages of company formation including securing initial funding, building successful management teams, forming impactful corporate alliances, and navigating the M&A acquisition or IPOs' process. We seek to build world class companies that aspire to dramatically improve the current state of medical care today and ultimately, the lives of patients. For more information, please visit www.sofinnova.com.
Logo - http://photos.prnewswire.com/prnh/20161013/428700LOGO
To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/sofinnova-raises-650-million-biotech-focused-venture-fund-300345277.html